Open AccessFeatures predicting colchicine efficacy in treatment of children with undefined systemic autoinflammatory disease: A retrospective cohort study
Author(s) -
Mariana Correia Marques,
AUTHOR_ID,
Buğra Han Egeli,
Holly Wobma,
Claudio Henrique T. Ribeiro,
Edwin L. Anderson,
Jonathan S Hausmann,
Fatma Dedeoğlu,
AUTHOR_ID,
AUTHOR_ID,
AUTHOR_ID,
AUTHOR_ID,
AUTHOR_ID,
AUTHOR_ID,
AUTHOR_ID,
AUTHOR_ID
Publication year - 2022
Publication title -
european journal of rheumatology
Language(s) - English
Resource type - Journals
eISSN - 2147-9720
pISSN - 2148-4279
DOI - 10.5152/eurjrheum.2022.21135
Subject(s) - medicine , colchicine , population , cohort , retrospective cohort study , familial mediterranean fever , dosing , pediatrics , disease , environmental health
Patients with undefined systemic autoinflammatory diseases (uSAIDs) are challenging to manage, as there are no guidelines or recommendations for targeted therapy. We aimed to evaluate the efficacy of empiric treatment with colchicine in our single-center uSAID population in the United States, as well as the patient characteristics associated with the most robust colchicine response.